Are you Dr. Franchi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
655 W 8th St
Acc Bldg, 5th Floor
Jacksonville, FL 32209Phone+1 904-244-7772
Summary
- Dr. Francesco Franchi, MD is a cardiologist in Jacksonville, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with UF Health Jacksonville.
Education & Training
- University of Modena Faculty of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2015 - 2025
Clinical Trials
- Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus Start of enrollment: 2019 Aug 22
- Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure Start of enrollment: 2020 Mar 30
- PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment Start of enrollment: 2021 Feb 09
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Switching from cangrelor to oral P2Yinhibitors: a focused review on drug-drug interactions.Giovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Davide Capodanno
Expert Opinion on Drug Metabolism & Toxicology. 2025-01-01 - International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.Dominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L Bhatt
JACC. Cardiovascular Interventions. 2024-11-25 - 1 citationsEvaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte
Clinical Pharmacology and Therapeutics. 2024-11-01
Authored Content
- The Quest for the Optimal Periprocedural Antithrombotic Treatment Strategy in ACS Patients Undergoing PCIMarch 2018
Press Mentions
- AHA 2022 Science Published Across JACC JournalsNovember 4th, 2022
- Meta-Analysis Supports Genotype-Guided P2Y12 Prescription for ACSMarch 25th, 2021
- UF Health Jacksonville First Site to Test Brilinta for Prevention of Excessive BleedingFebruary 18th, 2021
- Join now to see all